loading...| Preferred Name |
Warfarin |
|
| Synonyms |
Warfarin Sodium |
|
| Definitions |
An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D014859 |
|
| altLabel |
Warfarin Sodium Coumadine Warfarin Potassium Potassium, Warfarin Sodium, Warfarin Aldocumar Warfant Gen-Warfarin Coumadin Tedicumar Apo-Warfarin 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)- 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one Marevan |
|
| AN |
an anticoagulant & rodenticide |
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C1564397 C0043031 C1564394 C1564396 C0282378 C0376218 C1564393 C1564395 C1564392 C0699129 |
|
| DC |
1 |
|
| definition |
An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. |
|
| DX |
19660101 |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
I47IU4FOCO 5Q7ZVV76EI 0 6153CWM0CL |
|
| isa | ||
| LT |
TRD |
|
| Mapped from |
http://purl.bioontology.org/ontology/MESH/C531383 http://purl.bioontology.org/ontology/MESH/C062169 http://purl.bioontology.org/ontology/MESH/C094088 http://purl.bioontology.org/ontology/MESH/C536683 http://purl.bioontology.org/ontology/MESH/C031698 http://purl.bioontology.org/ontology/MESH/C070225 http://purl.bioontology.org/ontology/MESH/C087837 http://purl.bioontology.org/ontology/MESH/C101436 http://purl.bioontology.org/ontology/MESH/C065719 http://purl.bioontology.org/ontology/MESH/C048970 http://purl.bioontology.org/ontology/MESH/C013793 http://purl.bioontology.org/ontology/MESH/C071743 http://purl.bioontology.org/ontology/MESH/C038441 |
|
| MDA |
19990101 |
|
| MMR |
20160624 |
|
| MN |
D03.633.100.150.446.520.914 D03.383.663.283.446.520.914 |
|
| notation |
D014859 |
|
| PA |
D000925 D012378 |
|
| prefLabel |
Warfarin |
|
| RR |
I47IU4FOCO 81-81-2 (Warfarin) 6153CWM0CL |
|
| TERMUI |
T620653 T620657 T043412 T620655 T043415 T620661 T620651 T620649 T043414 T043413 T620659 T043411 |
|
| TH |
NLM (1996) US UK CA FDA SRS (2014) ES INN (19XX) DE AU USP (19XX) BAN (19XX) FR IE |
|
| tui |
T109 T131 T121 |
|
| subClassOf |